Dr.ssa Ines L'Erario

09/12/2023

01/12/2023

Primo concerto di Natale in arrivo! I nostri bambini e ragazzi rallegreranno con dolci canti il weekend di tanti nonni 🥰🎶

16/02/2023

S P O I L E R ‼️ Prove generali in corso.... 📿💍👑
17 FEBBRAIO 2023 ORE 18 TEATRO TRIANTE

29/11/2021

se ne parla sempre troppo poco

15/11/2021

https://www.infomedianews.com/vaccino-covid-e-bambini-parla-la-pediatra/?fbclid=IwAR1cNX-_OEaLf0bJs5gYuFtzkkLWJK4mEctV_ClCLxSFvtNLJIbzoFqgaTY

Governo pronto alla vaccinazione, si attende via libera dell'EMA

30/05/2021

Covid, ok dell’Ema alla vaccinazione nella fascia d’età 12-15 anni
Il comitato per i medicinali per uso umano (CHMP) dell’EMA ha raccomandato di concedere un'estensione di indicazione per Comirnaty, vaccino anti-COVID-19, in modo da includere l’uso nei bambini di età compresa tra 12 e 15 anni. Il vaccino è già approvato per gli adulti e gli adolescenti a partire dai 16 anni.
Questo il testo di approvazione dell'EMA
https://www.aifa.gov.it/documents/20142/1289823/2021.05.28_com-EMA_Comirnaty_approvato_12_15_anni_IT.pdf

26/04/2021

https://www.bmj.com/content/373/bmj.n1005

Covid-19 is associated with a far greater risk of cerebral venous thrombosis than the vaccinations that protect against it, early research from the University of Oxford has shown. The results, available as a non-peer reviewed preprint,1 show that the risk of cerebral venous thrombosis “is many-fol...

19/04/2021

Encouraging Findings About SARS-CoV-2 mRNA Vaccination During Pregnancy
Gray KJ et al. Am J Obstet Gynecol 2021 Mar 24

In pregnant and lactating persons, vaccine side effects and immune responses were similar to those in nonpregnant persons.

The clinical trials leading to the rollout of COVID-19 vaccines excluded pregnant women, despite large numbers of childbearing women in healthcare who were in the highest priority level for initial immunization in December 2020. To address this gap, a cohort of 84 pregnant, 31 lactating, and 16 nonpregnant women was studied throughout the course of receiving the Pfizer or Moderna mRNA vaccines.

Antibody titers following each vaccine dose were similar in pregnant, lactating, and nonpregnant women. Antibodies were transferred into breastmilk and cord blood, with titers rising with time after the boost. Immunoglobulin A (IgA) was noted following the initial immunization but was not boosted by the second vaccination. Side effects were consistent with known reactogenicity of these vaccines, with 32% of pregnant and 43% of lactating women reporting fever after the second dose.

COMMENT
In providing initial data on the immunologic responses to SARS-CoV-2 mRNA vaccines in pregnant and lactating persons, this study can be utilized by clinicians to encourage hesitant pregnant women to receive the vaccine. Optimal vaccine timing during pregnancy as well as neonatal protection require further study. The lack of these essential data when the vaccines were first rolled out has triggered stronger calls for including pregnant women in pivotal clinical trials.

23/03/2021

La Cura
https://www.uppa.it/nascere/neonato/neonati-pretermine-genitori-come-farmaci-naturali/?fbclid=IwAR3JPg81KMctP1jG6R6It1IZX6MvIwwS83qHUbA3ar_7aP8oRB6B1cLx6Ek

In che modo i genitori possono contribuire al benessero del loro bambino nato pretermine?

20/03/2021

keep calm, be informed and get vaccinated

https://blogs.bmj.com/bmj/2021/03/16/covid-19-in-italy-keep-calm-be-informed-and-get-vaccinated/?fbclid=IwAR2Z-W9R0hV9JASxFNHMPLN4H7dWU49x-haZqHQ3ahV49zqdDtrzIxf_EnM

The Italian Medicines Agency (Agenzia Italiana per il Farmaco – AIFA) has decided to stop administering the Oxford/AstraZeneca covid-19 vaccine “in the whole National territory, as a precaution and temporarily, [...]More...